These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 197133)

  • 21. [Evaluation of multiple myeloma with bone scintigraphy using Tc 99 diphosphonate. Review of the literature].
    Solis OJ; Gonzales R; De Luca S; McKusick KA; Potsaid MS
    Rev Interam Radiol; 1977 Apr; 2(2):71-5. PubMed ID: 866897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of technetium-99m to plasma proteins: influence on the distribution of Tc-99m phosphate agents.
    Schümichen C; Koch K; Kraus A; Kuhlicke G; Weiler K; Wenn A; Hoffman G
    J Nucl Med; 1980 Nov; 21(11):1080-5. PubMed ID: 7431108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
    Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
    J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential skeletal uptake of Tc-99m-tagged pyrophosphate and methylene diphosphonate in leukemia.
    Armas R; Neumann R; Goldsmith SJ
    J Nucl Med; 1983 Sep; 24(9):799-802. PubMed ID: 6310070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Technetium-99m phytate as a bone-marrow imaging agent: biodistribution studies in animals: concise communication.
    Hamilton RG; Alderson PO; Mclntyre PA
    J Nucl Med; 1977 Jun; 18(6):563-5. PubMed ID: 859038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bone imaging with 99m Tc-pyrophosphate].
    Fujiwara K; Watanabe N; Kawahara Y; Moriguchi T
    Rinsho Hoshasen; 1975 Dec; 20(13):1163-9. PubMed ID: 175200
    [No Abstract]   [Full Text] [Related]  

  • 27. Technetium-99m-Sn-pyrophosphate pharmaco-kinetics and bone image changes in parathyroid disease.
    Krishnamurthy GT; Brickman AS; Blahd WH
    J Nucl Med; 1977 Mar; 18(3):236-42. PubMed ID: 190364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A clinical comparison of Tc-99m HEDP and Tc-99m MDP in the detection of bone metastases: concise communication.
    Fogelman I; Citrin DL; McKillop JH; Turner JG; Bessent RG; Greig WR
    J Nucl Med; 1979 Feb; 20(2):98-101. PubMed ID: 430202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical comparison of technetium-99m diphosphonate and pyrophosphate in bone scintigraphy: concise communication.
    Silberstein EB; Maxon HR; Alexander GW; Rauf C; Bahr GK
    J Nucl Med; 1978 Feb; 19(2):161-3. PubMed ID: 203665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial uptake (rabbit) of six 99mTc-tagged pharmaceuticals and 85Sr after vasopressin-induced necrosis.
    Grossman ZD; Foster AB; McAfee JG; Richardson R; Subramanian G; Markarian B; Gagne G; Bassano D
    J Nucl Med; 1977 Jan; 18(1):51-6. PubMed ID: 187742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of technetium-99m pyrophosphate and technetium-99m methylene diphosphonate with variable amounts of stannous chloride in the detection of acute myocardial infarction.
    Huckell VF; Lyster DM; Morrison RT; Cooper JA
    Clin Nucl Med; 1985 Jul; 10(7):455-62. PubMed ID: 4028596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
    Godart G; Durez M; Bevilacqua M; Abramovici J; Robience Y
    Clin Nucl Med; 1986 Feb; 11(2):92-7. PubMed ID: 3769350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative lesion detection ability of Tc-99m HMDP and Tc-99m MDP: concise communication.
    Van Duzee BF; Schaefer JA; Ball JD; Chilton HM; Cowan RJ; Kuni C; Trow R; Watson NE
    J Nucl Med; 1984 Feb; 25(2):166-9. PubMed ID: 6233404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distributions of several agents useful in imaging myocardial infarcts.
    Bonte FJ; Parkey RW; Graham KD; Moore JG
    J Nucl Med; 1975 Feb; 16(2):132-5. PubMed ID: 162951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophoretic analysis of different technetium-99m (SnCl2) methylene diphosphonate complexes.
    Najafi A; Hutchison N
    J Nucl Med; 1985 May; 26(5):524-30. PubMed ID: 3157787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative studies of bone using (18)F-fluoride and (99m)Tc-methylene diphosphonate: evaluation of renal and whole-blood kinetics.
    Park-Holohan SJ; Blake GM; Fogelman I
    Nucl Med Commun; 2001 Sep; 22(9):1037-44. PubMed ID: 11505214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and in vivo biological investigations on a novel radioligand for bone scanning: technetium-99m-labeled zoledronic acid derivative.
    Lin J; Qiu L; Cheng W; Luo S; Ye W
    Nucl Med Biol; 2011 Jul; 38(5):619-29. PubMed ID: 21718936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication.
    Wang TS; Fawwaz RA; Johnson LJ; Mojdehi GE; Johnson PM
    J Nucl Med; 1980 Aug; 21(8):767-70. PubMed ID: 7400832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication.
    Mele M; Conte E; Fratello A; Pasculli D; Pieralice M; D'Addabbo A
    J Nucl Med; 1983 Apr; 24(4):334-8. PubMed ID: 6834136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significant differences amont the 99mTc-polyphosphates, 99mTc-pyrophosphates, and 99mTc-diphosphonates for bone imaging.
    Weber DA; Keyes JW; Wilson GA
    CRC Crit Rev Clin Radiol Nucl Med; 1977 Jan; 8(4):369-90. PubMed ID: 189966
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.